Bradford K. Amman - 20 Jun 2024 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role: Chief Financial Officer
Signature: /s/ Bradford K. Amman
Issuer symbol: VVOS
Transactions as of: 20 Jun 2024
Net transactions value: +$35,700
Form type: 4
Filing time: 28 Jun 2024, 20:53:46 UTC
Previous filing: 28 Dec 2022
Next filing: 27 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VVOS	Common Stock						80	20 Jun 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VVOS	Stock Option (Right to Buy)	Award	$35,700	+15,000	+90%	$2.38	31,667	20 Jun 2024	Common Stock	15,000	$2.38	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 20, 2024 (the "Grant Date"), the Reporting Person received a grant of 15,000 stock options from the Issuer. One-fifth vested immediately and one-fifth will vest annually on each anniversary of the Grant Date through June 20, 2028.